Page results
-
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
-
UCLH will play a vital role in a new respiratory virus study.
-
Research published in the latest issue of the Journal of Medical Genetics concludes that regularly monitoring women who carry BRCA gene alterations does provide some benefits.
-
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).
-
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
Following funding approval by NHS England, the Royal National Orthopaedic Hospital Trust (RNOH) will work with UCLH to implement an extension of our Epic Electronic Health Record (EHR).
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
-
The research team said the placenta acted as a barrier to transmission.
-
Prime Minister, Sir Keir Starmer, was joined by Health and Social Care Secretary, Wes Streeting, for a tour of the University College Hospital Grafton Way Building where they met staff and patients.
File results
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0081 - Consultant doctors headcount
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023